Liquid biopsy in cancer management: Integrating diagnostics and clinical applications.

Liquid biopsy is an innovative, minimally invasive diagnostic tool revolutionizing cancer management by enabling the detection and analysis of cancer-related biomarkers from bodily fluids such as blood, urine, or cerebrospinal fluid. Unlike traditional tissue biopsies, which require invasive procedures, liquid biopsy offers a more accessible and repeatable method for tracking cancer progression, detecting early-stage cancers, and monitoring therapeutic responses. The technology primarily focuses on analyzing circulating tumor cells (CTCs), circulating tumor DNA (ctDNA), and other cancer-derived genetic materials.

DTLMV2-A real-time deep transfer learning mask classifier for overcrowded spaces.

Through the commencement of the COVID-19 pandemic, the whole globe is in disarray and debating on unique approaches to stop this viral transmission. Masks are being worn by people all around the world as one of the preventative measures to avoid contracting this sickness. Although some people are following and adopting this precaution, others are not, despite official recommendations from the administration and public health organisations has been announced.